Treatment Action Group releases policy brief on US investments in tuberculosis research and development: A policy brief released by TAG today argues that decreasing US investment in TB research adds to the public health threat posed by TB to the United States and has already stalled the development of better and faster-acting treatment. Thanks to stagnant […]
The following is a guest post by Madhukar Pai of the McGill International TB Centre, Prashant Yadav of Montreal & Stephen M. Ross School of Business, and Ravi Anupindi of the University of Michigan, Ann Arbor. Whether it is mobile phone service or vacation travel, good businesses know that success depends on providing a complete and customer-centric solution. Should patients with tuberculosis […]
HIV
The recent news in Buzzfeed about volunteers who were recently discharged from their Peace Corps postings after being diagnosed with HIV stirred memories at the HIV […]
Tuberculosis
In a hospital serving an urban population, more than a third of patients with a confirmed TB diagnosis also had HIV. Of those, nearly three quarters […]
Research & Development
Tools to diagnose and monitor HIV, hepatitis B and C, and tuberculosis, as well as resistance to first-line TB treatment are among the tests included in […]
Policy
Infectious Diseases Society of America Senior Global Health Policy Specialist Rabita Aziz sent this dispatch from the 71st World Health Assembly in Geneva, where she will […]